Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease

Susan J. Brunskill, Christopher J. Hyde, Carolyn J. Doree, Suzanne M. Watt, Enca Martin-Rendon
  • European Journal of Heart Failure, August 2009, Wiley
  • DOI: 10.1093/eurjhf/hfp101
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Enca Martin-Rendon and Ms Susan Jane Brunskill